# MediScanAI — Phase A.3 Final Integrity & Evaluation Readiness Report

## 1. Executive Summary

This audit report delivers the independent quality verification of the **Phase A.3 Independent Online Evidence Adjudication** suite for the MediScanAI retrieval benchmark.

All 62 proposed benchmark records across 50 canonical cases were independently verified against authoritative primary medical and regulatory repositories. Zero candidate records were assumed valid without evidence verification. Two preliminary AI annotations were downgraded after discovering that the underlying disease chunks omitted symptoms that previous AI models had speculatively inferred.

> [!IMPORTANT]
> **Adjudication Boundary & Gold File State**  
> All records in this dataset are strictly marked `adjudicator_type: "ai_assisted_external_evidence"` with `human_reviewed: false`.  
> The official ground-truth file (`evaluation/benchmark/gold_judgments.jsonl`) remains unmodified at **zero bytes**.  
> The directory `entity_resolution/` was not inspected, accessed, traversed, or referenced.

---

## 2. Benchmark Reconciliation & Outcome Summary

### 2.1 Complete Record Reconciliation
| Dimension | Expected Count | Phase A.3 Count | Discrepancies | Audit Status |
| :--- | :---: | :---: | :---: | :--- |
| **Canonical Benchmark Queries** | 50 | 50 | 0 | Perfect Parity |
| **Corpus Candidate Judgments** | 57 | 57 | 0 | Perfect Parity |
| **Negative Control Queries** | 5 | 5 | 0 | Perfect Parity |
| **Total Evaluated Records** | **62** | **62** | **0** | **100% Accounted For** |
| **Authoritative Source Entities** | 35 | 35 | 0 | 100% Tier 1 Coverage |
| **Unresolved Findings** | 0 | 0 | 0 | Zero Unresolved Cases |
| **Insufficient Evidence Cases** | 0 | 0 | 0 | Zero Unsubstantiated Claims |

### 2.2 Adjudication Status Counts
- **`evidence_verified`:** 55 records (88.7%) — Preliminary grade fully corroborated by source text.
- **`grade_changed_after_research`:** 2 records (3.2%) — Preliminary grade downgraded from 2 to 1 due to Rule 4.2 compliance.
- **`negative_control_verified`:** 5 records (8.1%) — Verified as unanswerable or clinically false assertions against FDA/WHO registries.
- **`unresolved`:** 0 records (0.0%).
- **`insufficient_source_evidence`:** 0 records (0.0%).
- **Total Coverage:** **100.0%** of benchmark claims verified against authoritative primary evidence.

---

## 3. Key Findings: Strict Enforcement of Rule 4.2

The primary finding of Phase A.3 is that preliminary AI annotators tend to project clinical associations onto text chunks that lack the actual symptom mentions. Phase A.3 eliminated this source of evaluation noise:

### Summary of Corrected Records
1. **MED-BENCH-037 (`disease_chunk_501` for `"Cough and fever"`):**
   - *Preliminary Grade:* 2 $\rightarrow$ *Evidence-Based Grade:* **1** (Delta: -1)
   - *Discrepancy:* `chunk_501` (Acute sinusitis) documents fever, nasal congestion, and sinus pressure, but contains **zero occurrences of "cough"**.
   - *Adjudication Rule:* Rule 4.2 (Free-Text Inference Prohibition) forbids assuming post-nasal drip cough when unstated in the source record. Presenting only fever is weak partial overlap (Grade 1).
2. **MED-BENCH-039 (`disease_chunk_89` for `"Fatigue and dizziness"`):**
   - *Preliminary Grade:* 2 $\rightarrow$ *Evidence-Based Grade:* **1** (Delta: -1)
   - *Discrepancy:* `chunk_89` (Type 2 Diabetes) documents fatigue, polyuria, polydipsia, and delayed healing, but contains **zero occurrences of "dizziness"**.
   - *Adjudication Rule:* Rule 4.2 forbids inferring dizziness from glycemic fluctuations. Presenting only fatigue without dizziness is weak partial overlap (Grade 1).

### Comparison with True Supporting Evidence
In contrast, `disease_chunk_160` (Hypothyroidism for `"Fatigue and dizziness"`) was verified and retained at **Grade 2** because both `'Fatigue'` and `'dizziness'` are explicitly present in the chunk symptom list.

---

## 4. Programmatic Quality Checks & Validation Results

An automated integrity verification suite validated the new Phase A.3 artifacts against all contractual constraints:

| Verification Check | Target Requirement | Actual Result | Status |
| :--- | :--- | :--- | :---: |
| **Record Count Parity** | Exactly 62 rows | 62 rows in judgments & CSV | PASSED |
| **Case ID Parity** | 50 canonical case IDs (`MED-BENCH-001..050`) | All 50 IDs represented | PASSED |
| **Evidence ID Consistency** | Match canonical candidate & negative control IDs | 57 corpus IDs + 5 `none` IDs | PASSED |
| **Grade Schema Conformance** | Integer $\in \{0, 1, 2, 3\}$ | All 62 grades valid | PASSED |
| **Source Provenance Mapping** | Every judgment links to valid source in registry | 62 / 62 mapped to 35 registry keys | PASSED |
| **Grade Delta Exposure** | All grade revisions documented in CSV & JSONL | Both changes exposed with deltas | PASSED |
| **Negative Control Isolation**| Evaluated separately; grade 0 with rationale | 5 / 5 verified against FDA/WHO | PASSED |
| **No Fabricated Human Status**| `human_reviewed: false`, `adjudicator_type: "ai_assisted_external_evidence"` | 62 / 62 marked non-human | PASSED |
| **Gold File Inviolability** | `evaluation/benchmark/gold_judgments.jsonl` == 0 bytes | 0 bytes (unmodified) | PASSED |
| **Off-Limits Boundary** | `entity_resolution/` untouched | 0 accesses, 0 references | PASSED |

---

## 5. Test Suite Execution

The existing non-mutating evaluation benchmark test suites were executed to verify zero regression across the repository:

### Test Execution Command
```bash
pytest tests/unit/test_evaluation_benchmark.py tests/unit/test_retrieval_evaluation.py -v
```

### Result
- **Passed:** 92 unit tests in 3.05 seconds.
- **Failures:** 0.
- **Errors:** 0.
- **Working Tree State:** Clean on all tracked git files.

---

## 6. Evaluation Readiness Decision & Operational Recommendations

### 6.1 Readiness Determination
The Phase A.3 dataset (`evidence_verified_judgments.jsonl`) is **fully certified for AI-assisted research evaluation runs**. It provides complete, auditable, and traceable coverage across all 50 benchmark queries and 62 candidate evidence items.

### 6.2 Operational Execution Rules for Benchmark Evaluation
When running retrieval evaluation harnesses using this dataset:
1. **Isolated Run Configuration:** Configure the evaluation harness to read from `evaluation/benchmark/evidence_adjudication/phase_a_3/evidence_verified_judgments.jsonl` rather than `gold_judgments.jsonl`.
2. **Explicit Labeling:** Any metric tables, markdown summaries, or dashboards generated from this dataset must be explicitly titled:
   `"MediScanAI Retrieval Benchmark — AI-Assisted Evidence-Verified Evaluation"`.
3. **No Promotion to Gold:** Do NOT copy, symlink, or write these records into `evaluation/benchmark/gold_judgments.jsonl`. Official gold ground truth remains reserved for licensed clinician review (Phase A.4).
4. **Primary vs. Strict Thresholds:**
   - Under the Primary Operational Threshold ($\text{Rel} \ge 2$), the benchmark contains **54 relevant records** ($45 \text{ Grade 3} + 9 \text{ Grade 2}$).
   - Under the Strict Clinical Threshold ($\text{Rel} = 3$), the benchmark contains **45 relevant records**.
   - The 3 Grade 1 records and 5 Grade 0 negative control records are evaluated as irrelevant ($\text{Rel} = 0$).

---

## 7. Deliverables Index

All Phase A.3 deliverables are located in `evaluation/benchmark/evidence_adjudication/phase_a_3/`:

1. `evidence_verified_judgments.jsonl` — 62 machine-readable adjudicated judgments.
2. `source_registry.jsonl` — 35 authoritative Tier 1 source profiles with URLs and excerpts.
3. `grade_comparison.csv` — Full 62-row tabular comparison exposing preliminary vs. evidence-based grades.
4. `coverage_report.md` — Detailed statistical breakdown and clinical case coverage analysis.
5. `unresolved_findings.jsonl` — Ledger of unresolved findings (0 records; complete resolution).
6. `methodology.md` — Comprehensive 10-step adjudication procedure and source hierarchy.
7. `final_integrity_report.md` — This certified audit and evaluation readiness report.
